Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
3/27/15 Opko (OPK) Rayaldee for Hyperparathyroidism (Secondary) Subscribers Only Subscribers Only Subscribers Only
3/27/15 Northwest Biotherapeutics (NWBO) DCVax-Brain for Brain Cancer (malignant glioma; AA and GBM) Subscribers Only Subscribers Only Subscribers Only
3/27/15 Ohr (OHRP) Squalamine Eye Drops for Wet Age-Related Macular Degeneration (Wet AMD) (Ophthalmology) Subscribers Only Subscribers Only Subscribers Only
3/27/15 PharmaCyte Biotech (PHCB) Encapsulated Cytochrome P450 Expressing Cells for Pancreatic Cancer Subscribers Only Subscribers Only Subscribers Only
3/26/15 Genfit (GNFT:FP) GFT505 for Non-alcoholic Steatohepatitis (NASH) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
03/27/15 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
03/27/15 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
03/28/15 Subscribers Only Subscribers Only Trial Data - Updated Results
03/28/15 Subscribers Only Subscribers Only Trial Data - Other
03/28/15 Subscribers Only Subscribers Only Trial Data - Updated Results